While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.

Jared Holz, Mizuho healthcare sector specialist, joins 'Fast Money' to talk rising rates and how the biotech sector is ...

Biotech companies are strange businesses to think about in terms of competitive advantages. A software company can lock customers into an ecosystem for years. A manufacturer can have a cost advantage.

When Xaira Therapeutics debuted in 2024 with a gobsmacking $1 billion in funding, a natural expectation would have been for a ...

Kodiak Sciences tripled in a single session after its eye drug cleared a pivotal trial, but a cash-burning biotech with no ...

Readers weigh in on the 2026 Healthcare Roundtable, Dan Fuss’ advice, the AI revolution, and safety of investor assets.

Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...

Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced data published in the Proceedings of the ...

VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...